Suchergebnisse - "Thurman, Michellie"

PubPharm (8)

1

Pathways for Dolutegravir Transformation from a Daily Oral to a Once-a-Year Parenteral Medicine

enthalten in: ResearchSquare.com | 2022

von Deodhar, S. | Sillman, B. | Bade, A. | +17

2

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

enthalten in: Nature communications | 2022

von Deodhar, S. | Sillman, B. | Bade, A. | +20

3

Chronic Morphine Exposure distorts Gut-Brain Interrelationships in SHIV Infected Rhesus Macaques

enthalten in: ResearchSquare.com | 2022

von Olwenyi, O. | Johnson, S. | Bidokhti, M. | +10

4

Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2022

von Ripperda, T. | Yu, Y. | Verma, A. | +4

5

PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron

enthalten in: Clinical and translational medicine | 2022

von Acharya, A. | Pathania, A. | Pandey, K. | +6

6

Early treatment with anti-α4β7 antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques

enthalten in: Frontiers in immunology | 2022

von Johnson, S. | Knight, L. | Kumar, N. | +5

7

Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques

enthalten in: Frontiers in neuroscience | 2022

von Olwenyi, O. | Johnson, S. | Bidokhti, M. | +10

8

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron

enthalten in: Clinical and Translational Medicine | 2022

von Acharya, A. | Pathania, A. | Pandey, K. | +6

1
[1]